NFKB1 and lung carcinoma: Since the pleiotropic NF-κB signaling pathway is pivotal for lung cancer metastasis, NF-κB signaling has been targeted for the inhibition of lung cancer, for example, by using proteosome inhibitors like bortezomib and carfilzomib [47].